User menu

Effect of Visceral Disease Site on Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide in the PREVAIL Trial.

Bibliographic reference Alumkal, Joshi J ; Chowdhury, Simon ; Loriot, Yohann ; Sternberg, Cora N ; de Bono, Johann S ; et. al. Effect of Visceral Disease Site on Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide in the PREVAIL Trial.. In: Clinical Genitourinary Cancer, Vol. 15, no.5, p. 610-617.e3 (2017)
Permanent URL http://hdl.handle.net/2078.1/187985